ARYD ARYA Sciences Acquisition Corp IV - Class A
ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
On 9/29/2021 the company announced a proposed merger with Caritas Therapeutics, Inc, a next-generation genetic medicine company, but the merger was terminated 2/24/2022.
$10.30 -0.02 (-0.19%)
As of 03/23/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1: US Equity
Category2: Common stocks
Category3: Micro cap
GICS sector: Financials
Industry: Shell Companies
Index country: USA
Country of incorporation:
IPO date: 02/26/2021
Outstanding shares: 15,449,000
Average volume: 11,981
Market cap: $159,124,700
Current dividend yield: 0.00%
All SEC filings: SEC Edgar Online
Quarterly filings: 10-Q
Annual filings: 10-K
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%